Market Overview:
Embolization utilizes minimally invasive techniques to occlude or block blood flow in blood vessels to prevent or treat bleeding. It involves injecting small particles or devices called embolic agents through a catheter inserted into an artery to reduce or stop blood flow to an area of abnormal vascularity or hemorrhage.

Market key trends:
One of the major trend in the Embolization Market is the growing preference for minimally invasive procedures over traditional open surgeries. Minimally invasive procedures such as embolization offer various advantages compared to traditional surgeries such as reduced trauma, reduced risk of infection, shorter hospital stay and faster recovery time. Embolization procedures do not require large incisions and can be performed through small punctures using interventional devices. This has increased the adoption of embolization procedures for treating various conditions such as uterine fibroids, tumors, arterial venous malformations and others.
SWOT Analysis

Strength: The embolization market has high growth potential owing to rising prevalence of chronic diseases and increasing adoption of minimally invasive procedures. It provides shorter recovery time and less complications compared to open surgeries.

Weakness: Lack of skilled professionals for performing complex embolization procedures and high cost of treatment are the major limitations. Additionally, risks associated with exposure to radiation during procedures hinders the market growth.

Opportunity: Increasing healthcare expenditure in emerging nations and technological advancements in embolization devices offer lucrative growth opportunities. Growing application areas such as uterine fibroid embolization and prostate artery embolization further supports the market expansion.

Threats: Strict regulatory approval process and post marketing surveillance delays the product launch. Moreover, availability of alternative treatment options like laparoscopic surgeries poses a threat to the embolization market growth.

Key Takeaways

The Global Embolization Market Share is expected to witness high growth, exhibiting CAGR of 8.1% over the forecast period, due to increasing prevalence of chronic diseases and growing adoption of minimally invasive procedures.

North America dominates the global embolization market and is expected to continue its dominance over the forecast period owing to increasing healthcare expenditure, technological advancements and growing obesity rates in the region. Asia Pacific is projected to exhibit the fastest growth rate during the analysis period due to rising medical tourism, surge in healthcare infrastructure and growing geriatric population in countries like India and China.

Key players operating in the embolization market are IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson.

Read More: